Auteurs
Checkpoint
Ncbi
Racine
Checkpoint
Ncbi
Exploration
Accueil
Racine
Racine

Serveur d'exploration Tocilizumab - Checkpoint (Ncbi)

Index « Auteurs » - entrée « Shunsuke Mori »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Shunsuke Miura < Shunsuke Mori < Shunsuke Sasaoka  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 15.
Ident.Authors (with country if any)Title
000352 (2011) Hideto Kameda [Japon] ; Hitoshi Tokuda ; Fumikazu Sakai ; Takeshi Johkoh ; Shunsuke Mori ; Yuji Yoshida ; Noboru Takayanagi ; Hirofumi Taki ; Yoshinori Hasegawa ; Kazuhiro Hatta ; Hisashi Yamanaka ; Makoto Dohi ; Shu Hashimoto ; Hidehiro Yamada ; Shinichi Kawai ; Tsutomu Takeuchi ; Kazuhiro Tateda ; Hajime GotoClinical and radiological features of acute-onset diffuse interstitial lung diseases in patients with rheumatoid arthritis receiving treatment with biological agents: importance of Pneumocystis pneumonia in Japan revealed by a multicenter study.
000386 (2011) Shunsuke Mori [Japon] ; Yukitaka UekiPrimary lack of efficacy of infliximab therapy for rheumatoid arthritis: pharmacokinetic characterization and assessment of switching to tocilizumab.
000478 (2012) Shunsuke Mori [Japon] ; Kaoru Terada ; Yukitaka UekiTocilizumab-induced hyperbilirubinemia in Japanese patients with rheumatoid arthritis: its association with UDP glucuronosyltransferase 1A1 gene polymorphisms.
000516 (2012) Shunsuke Mori [Japon] ; Hitoshi Tokuda ; Fumikazu Sakai ; Takeshi Johkoh ; Akio Mimori ; Norihiro Nishimoto ; Sadatomo Tasaka ; Kazuhiro Hatta ; Hidekazu Matsushima ; Shunji Kaise ; Atsushi Kaneko ; Shigeki Makino ; Seiji Minota ; Takashi Yamada ; Shinobu Akagawa ; Atsuyuki KurashimaRadiological features and therapeutic responses of pulmonary nontuberculous mycobacterial disease in rheumatoid arthritis patients receiving biological agents: a retrospective multicenter study in Japan.
000543 (2012) Shunsuke MoriAdditional use of tacrolimus after switching to tocilizumab therapy in patients with primary lack of efficacy of infliximab therapy for rheumatoid arthritis.
000639 (2012) Shunsuke Mori [Japon] ; Yukitaka Ueki ; Naoyuki Hirakata ; Motohiro Oribe ; Toshihiko Hidaka ; Kazunori OishiImpact of tocilizumab therapy on antibody response to influenza vaccine in patients with rheumatoid arthritis.
000655 (2012) Shunsuke Mori ; Shigetoshi FujiyamaComment on: Tocilizumab treatment in a patient suffering from rheumatoid arthritis and concomitant chronic hepatitis C infection.
000738 (2013) Shunsuke Mori [Japon] ; Yukitaka Ueki ; Yukihiro Akeda ; Naoyuki Hirakata ; Motohiro Oribe ; Yoshiki Shiohira ; Toshihiko Hidaka ; Kazunori OishiPneumococcal polysaccharide vaccination in rheumatoid arthritis patients receiving tocilizumab therapy.
000B04 (2016) Shunsuke Mori [Japon] ; Yukinori Koga [Japon]Glucocorticoid-resistant polymyalgia rheumatica: pretreatment characteristics and tocilizumab therapy.
000C97 (2015) Shunsuke Mori [Japon] ; Tamami Yoshitama [Japon] ; Toshihiko Hidaka [Japon] ; Naoyuki Hirakata [Japon] ; Yukitaka Ueki [Japon]Effectiveness and safety of tocilizumab therapy for patients with rheumatoid arthritis and renal insufficiency: a real-life registry study in Japan (the ACTRA-RI study).
000F32 (2015) Shunsuke Mori [Japon] ; Mineharu Sugimoto [Japon]Pneumocystis jirovecii Pneumonia in Rheumatoid Arthritis Patients: Risks and Prophylaxis Recommendations
000F38 (2015) Shunsuke Mori ; Shigetoshi FujiyamaHepatitis B virus reactivation associated with antirheumatic therapy: Risk and prophylaxis recommendations
001615 (2017) Shunsuke Mori [Japon] ; Tamami Yoshitama [Japon] ; Toshihiko Hidaka [Japon] ; Fumikazu Sakai [Japon] ; Mizue Hasegawa ; Yayoi Hashiba [Japon] ; Eiichi Suematsu [Japon] ; Hiroshi Tatsukawa [Japon] ; Akinari Mizokami [Japon] ; Shigeru Yoshizawa [Japon] ; Naoyuki Hirakata [Japon] ; Yukitaka Ueki [Japon]Comparative risk of hospitalized infection between biological agents in rheumatoid arthritis patients: A multicenter retrospective cohort study in Japan.
001726 (2017) Shunsuke Mori ; Tamami Yoshitama ; Naoyuki Hirakata ; Yukitaka UekiPrevalence of and factors associated with renal dysfunction in rheumatoid arthritis patients: a cross-sectional study in community hospitals
001E19 (2019) Shunsuke Mori [Japon] ; Tamami Yoshitama [Japon] ; Yasuyo Abe [Japon] ; Toshihiko Hidaka [Japon] ; Naoyuki Hirakata [Japon] ; Kiyoshi Aoyagi [Japon] ; Yukitaka Ueki [Japon]Retention of tocilizumab with and without methotrexate during maintenance therapy for rheumatoid arthritis: the ACTRA-RI cohort study.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/Ncbi/Checkpoint

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/Author.i -k "Shunsuke Mori" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/Author.i  \
                -Sk "Shunsuke Mori" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Checkpoint/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    Ncbi
   |étape=   Checkpoint
   |type=    indexItem
   |index=    Author.i
   |clé=    Shunsuke Mori
}}
Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021